The Torch

Wave of Women Column: New FDA Approved Postpartum Depression Drug Won’t Be Accessible For Most Women

Wave of Women Column: New FDA Approved Postpartum Depression Drug Won’t Be Accessible For Most Women

Destinee Scott, Staff Writer

March 27, 2019

For the first time ever, the US Food and Drug Administration (FDA) has approved a postpartum depression drug, which experts say offers new hope to women and physicians — but the cost of it is a huge chunk of the salary of an average American. The intravenous infusion of the drug, brexanolone, which will co...

The Independent Student Newspaper of St. John's University
drug